Abiopharma

🔍 Maheshwari Anshul (Executive)

Company: SI-BONE, Inc. (SIBN)

Report Date: 2026-08-17

Detailed Transactions and Holdings:

• Sold 2,476 shares of Common Stock at $18.6798 per share (Direct)
  Date: 2026-08-17 | Code: S | equity_swap_involved: false | shares_owned_after: 254,084.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 2,189 shares of Common Stock at $18.6224 per share (Direct)
  Date: 2026-08-17 | Code: S | equity_swap_involved: false | shares_owned_after: 251,895.00 | transaction_form_type: 4 | Footnotes: F1, F3, F4

Footnotes:

• F1: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
• F2: This transaction was executed in multiple trades at prices ranging from $18.54 USD to $18.79 USD; the price reported above reflects the weighted average sale price.
• F3: This transaction was executed in multiple trades at prices ranging from $18.515 USD to $18.73 USD; the price reported above reflects the weighted average sale price.
• F4: Includes 167,604 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.